64 Biggest Movers From Yesterday

Gainers

• Eltek Ltd. (NASDAQ:ELTK) shares climbed 326.8 percent to close at $7.00 on Wednesday after reporting Q1 results. Eltek posted Q1 earnings of $0.12 per share, versus a year-ago loss of $0.33 per share.
• Obalon Therapeutics, Inc. (NASDAQ:OBLN) shares rose 58.3 percent to close at $1.13.
• Soliton, Inc. (NASDAQ:SOLY) shares gained 42.6 percent to close at $20.28 on continued strength after the company on Tuesday received FDA 510(k) approval for its acoustic wave device for dermal tattoo clearing.
• Rewalk Robotics Ltd (NASDAQ:RWLK) climbed 37.4 percent to close at $4.08 after the company received CE mark for its ReStore Exo-Suit stroke rehabilitation device.
• Valeritas Holdings, Inc. (NASDAQ:VLRX) shares gained 37.3 percent to close at $3.90 after surging 22.94 percent on Tuesday. Valeritas reaffirmed its Q2 and FY19 sales guidance and disclosed that it will participate in American Diabetes Association's Scientific Sessions June 7-11.
• Chaparral Energy, Inc. (NYSE:CHAP) rose 22.9 percent to close at $4.46.
• Netshoes (Cayman) Limited (NYSE:NETS) gained 21.3 percent to close at $3.70 after SBF Group reportedly raised its offer to acquire the company to $3.50 per share.
• Technical Communications Corporation (NASDAQ:TCCO) rose 20.7 percent to close at $3.96 after announcing orders valued at $2.7 million to secure military communications.
• Cara Therapeutics Inc (NASDAQ:CARA) climbed 20 percent to close at $21.57 after the company announced results from its KALM-1 pivotal Phase 3 trial of KORSUVA showed significant improvement in primary and secondary endpoints.
• Attis Industries, Inc. (NASDAQ:ATIS) rose 19.2 percent to close at $2.79.
• Beyond Meat, Inc. (NASDAQ:BYND) surged 13.4 percent to close at $97.50.
• Columbus McKinnon Corporation (NASDAQ:CMCO) gained 12.6 percent to close at $36.70 following upbeat Q4 results.
• InspireMD, Inc. (NYSE:NSPR) gained 12.6 percent to close at $3.84.
• Cypress Semiconductor Corporation (NASDAQ:CY) rose 12 percent to close at $17.25 after Bloomberg reported there is takeover interest.
• Aptose Biosciences Inc. (NASDAQ:APTO) gained 11.9 percent to close at $2.25.
• Heico Corp (NYSE:HEI) shares rose 11.7 percent to close at $117.14 after the company reported better-than-expected results for its second quarter on Tuesday.
• Amarin Corporation plc (NASDAQ:AMRN) gained 11.6 percent to close at $18.99 after the FDA granted priority review to the company's supplemental new drug application for Vascepa to reduce residual cardiovascular risk in patients with statin-managed LDL-C cholesterol.
• Fibrocell Science Inc (NASDAQ:FCSC) climbed 10.7 percent to close at $2.07 after the company received FDA regenerative medicine advanced therapy designation for FCX-007 Gene Therapy for the treatment of RDEB.
• Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) gained 9.8 percent to close at $7.99.
• BioSig Technologies, Inc. (NASDAQ:BSGM) climbed 9.7 percent to close at $7.24.
• Chiasma, Inc. (NASDAQ:CHMA) shares jumped 9.7 percent to close at $7.48.
• Sesen Bio, Inc. (NASDAQ:SESN) gained 8.4 percent to close at $2.46.
• Conformis, Inc. (NASDAQ:CFMS) surged 8.2 percent to close at $3.44.
• AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) gained 8 percent to close at $2.83.
• Frontier Communications Corp (NASDAQ:FTR) rose 7 percent to close at $1.85 after the company reported the sale of its operations in multiple states for $1.352 billion.
• So-Young International Inc. (NASDAQ:SY) jumped 5.9 percent to close at $15.52.
• YY Inc. (NASDAQ:YY) shares rose 4.8 percent to close at $66.98 after the company reported better-than-expected Q1 sales.
• PDS Biotechnology Corporation (NASDAQ:PDSB) gained 4.6 percent to close at $7.06. PDS Biotech disclosed that it has signed a Cooperative R&D deal with National Cancer Institute to perform Phase 2 study of PDS0101 in combo with other immune-modulating agents in advanced HPV-related cancers.
• Bloomin' Brands Inc (NASDAQ:BLMN) gained 4.1 percent to close at $19.20 after it was reported that the company would replace Travelport Worldwide Limited in the S&P Small Cap 600.

 

Losers

• Canada Goose Holdings Inc. (NYSE:GOOS) shares dipped 30.9 percent to close at $33.89 on Wednesday following Q1 results. Canada Goose reported first-quarter adjusted earnings per share of 9 cents in Canadian dollars, up from 7 cents in the same period last year. The group reported sales of C$156.2 million, up from C$124.8 million in the first quarter of 2018.
• Altisource Asset Management Corporation (NYSE:AAMC) shares fell 30.7 percent to close at $14.07.
• Evolent Health, Inc. (NYSE:EVH) fell 29.3 percent to close at $10.01. Evolent Health expanded partnership with Passport Health Plan to support medicaid beneficiaries in the commonwealth of Kentucky.
• Nordic American Offshore Ltd. (NYSE:NAO) dipped 27.2 percent to close at $3.10.
• Abercrombie & Fitch Co. (NYSE:ANF) shares fell 26.5 percent to close at $18.39 after the company reported downbeat same-store sales for the first quarter and issued a weak outlook.
• TuanChe Limited (NASDAQ:TC) tumbled 20 percent to close at $4.24.
• Bridgeline Digital, Inc. (NASDAQ:BLIN) dipped 18.1 percent to close at $3.27.
• Hudson Technologies Inc. (NASDAQ:HDSN) dropped 16.4 percent to close at $1.68.
• Libbey Inc. (NYSE:LBY) shares fell 14.6 percent to close at $1.87.
• Navios Maritime Holdings Inc. (NYSE:NM) dropped 14 percent to close at $3.07.
• Wrap Technologies, Inc. (NASDAQ:WRTC) fell 12.8 percent to close at $6.04.
• X Financial (NYSE:XYF) shares declined 12.4 percent to close at $4.25.
• Appliance Recycling Centers of America, Inc. (NASDAQ:ARCI) slipped 12.4 percent to close at $4.96.
• J.Jill, Inc. (NYSE:JILL) fell 12.4 percent to close at $3.61.
• TransMedics Group, Inc. (NASDAQ:TMDX) shares dropped 12.1 percent to close at $26.50.
• Immunic, Inc. (NASDAQ:IMUX) fell 12 percent to close at $9.38.
• Atlantic Power Corporation (NYSE:AT) tumbled 11.5 percent to close at $2.31.
• Selecta Biosciences, Inc. (NASDAQ:SELB) dropped 11.3 percent to close at $2.04.
• Safe-T Group Ltd (NASDAQ:SFET) dipped 11.1 percent to close at $2.01.
• Outlook Therapeutics, Inc. (NASDAQ:OTLK) shares fell 10.8 percent to close at $2.55.
• Sorrento Therapeutics, Inc. (NASDAQ:SRNE) dropped 10.3 percent to close at $2.95.
• CalAmp Corp. (NASDAQ:CAMP) fell 10.2 percent to close at $10.94. Goldman Sachs downgraded CalAmp from Neutral to Sell and lowered the price target from $13 to $11.
• Zafgen, Inc. (NASDAQ:ZFGN) dipped 10.2 percent to close at $2.39.
• Digital Ally, Inc. (NASDAQ:DGLY) tumbled 10 percent to close at $2.53.
• Capri Holdings Limited (NYSE:CPRI) fell 9.9 percent to close at $35.06. Capri posted upbeat Q4 results, but issued weak profit forecast for the first quarter. Capri said it expects to incur restructuring charges of up to $30 million in FY20 related to Michael Kors store closures.
• Melinta Therapeutics, Inc. (NASDAQ:MLNT) dropped 9.9 percent to close at $2.2700.
• e.l.f. Beauty, Inc. (NYSE:ELF) fell 9 percent to close at $10.52.
• RAVE Restaurant Group, Inc. (NASDAQ:RAVE) dropped 8.4 percent to close at $2.19.
• Exela Technologies, Inc. (NASDAQ:XELA) fell 8.4 percent to close at $2.19.
• Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) dipped 7.3 percent to close at $2.04.
• Daktronics, Inc. (NASDAQ:DAKT) shares fell 7.1 percent to close at $6.73 after reporting downbeat Q4 results.
• Genesco Inc. (NYSE:GCO) slipped 6 percent to close at $40.66.
• Dicks Sporting Goods Inc (NYSE:DKS) fell 5.9 percent to close at $33.67 after the company posted upbeat Q1 results and raised FY19 EPS guidance.
• Workday, Inc. (NASDAQ:WDAY) dropped 4.5 percent to close at $203.23 following Q1 results.
• Johnson & Johnson (NYSE:JNJ) fell 4.2 percent to close at $131.33 after the company's trial in Oklahoma regarding its role in opioid addiction began on Tuesday.